Painchek Ltd has released a press release.
Response to ASX Aware Letter
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from PainChek
- PainChek Secures First US Customer Following FDA Clearance
- PainChek FDA Cleared to Commence Sales in US$100M US Market
- Trading Halt
- Compelling Clinical and Economic Results in Scottish Pilot
- Preliminary Final Report
Later from PainChek
- Key hire to drive Infant App in $15Bn addressable market
- Notice of Annual General Meeting/Proxy Form
- Investor Presentation
- AGM Presentation
- PainChek gains access to RTM reimbursement in USA
Follow PainChek into a list and get an email when it puts out news.
Follow PainChek